Investing.com - Revolution Med (NASDAQ: RVMD) reported fourth quarter EPS of $-0.63, $0.19 better than the analyst estimate of $-0.82. Revenue for the quarter came in at $15.33M versus the consensus estimate of $7.8M.
Revolution Med's stock price closed at $24.37. It is up 3.00% in the last 3 months and up 31.30% in the last 12 months.
Revolution Med saw 3 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Revolution Med's stock price’s past reactions to earnings here.
According to InvestingPro, Revolution Med's Financial Health score is "weak performance".
Check out Revolution Med's recent earnings performance, and Revolution Med's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar